Ausgabe 5/2021
Inhalt (32 Artikel)
Perspectives on the Future Development of Mobile Applications for Dermatology Clinical Research
Edward Hadeler, Julie Hong, Megan Mosca, Marwa Hakimi, Nicholas Brownstone, Tina Bhutani, Wilson Liao
Dermatologic Care of Hair in Transgender Patients: A Systematic Review of Literature
Catherine C. Motosko, Antonella Tosti
Review of the Latest Methods of Epidermolysis Bullosa and Other Chronic Wounds Treatment Including BIOOPA Dressing
Magdalena Nita, Jacek Pliszczyński, Maciej Kosieradzki, Piotr Fiedor
Current Trends of Immunotherapy in the Treatment of Cutaneous Melanoma: A Review
Piyu Parth Naik
Psoriasis and Cardiometabolic Comorbidities: An Evaluation of the Impact of Systemic Treatments in Randomized Clinical Trials
Megan Mosca, Julie Hong, Edward Hadeler, Marwa Hakimi, Nicholas Brownstone, Wilson Liao, Tina Bhutani
The Unmet Needs in Atopic Dermatitis Control in Latin America: A Multidisciplinary Expert Perspective
Jorge Sanchez, Ivan Cherrez-Ojeda, Cesar Galvan, Elizabeth Garcia, Natalia Hernández-Mantilla, Angela Londoño Garcia, Elizabeth McElwee, Mariana Rico Restrepo, Enrique Rivas, Benjamin Hidalgo
Mast Cell Stabilizers in the Treatment of Rosacea: A Review of Existing and Emerging Therapies
Mark C. Marchitto, Anna L. Chien
Psychometric Validation of the Psoriasis Symptoms and Impacts Measure (P-SIM), a Novel Patient-Reported Outcome Instrument for Patients with Plaque Psoriasis, Using Data from the BE VIVID and BE READY Phase 3 Trials
Richard B. Warren, Alice B. Gottlieb, Joseph F. Merola, Llenalia Garcia, Christopher Cioffi, Luke Peterson, Christopher Pelligra, Valerie Ciaravino
Inadequate Disease Control, Treatment Dissatisfaction, and Quality-of-Life Impairments Among US Patients Receiving Topical Therapy for Atopic Dermatitis
Peter Anderson, Jenny Austin, Jennifer H. Lofland, James Piercy, Vijay N. Joish
Efficacy and Safety of Platelet-Rich Plasma in Melasma: A Systematic Review and Meta-Analysis
Lingyun Zhao, Meng Hu, Qing Xiao, Runke Zhou, Yu Li, Lidan Xiong, Li Li
Baricitinib Rapidly Improves Skin Pain Resulting in Improved Quality of Life for Patients with Atopic Dermatitis: Analyses from BREEZE-AD1, 2, and 7
Jacob P. Thyssen, Timo Buhl, Pablo Fernández-Peñas, Kenji Kabashima, Sherry Chen, Na Lu, Amy M. DeLozier, Marta Casillas, Sonja Ständer
Secukinumab Demonstrated High Effectiveness in Vietnamese Patients with Moderate-To-Severe Plaque Psoriasis in a Real-World Clinical Setting: 16 Week Results from an Observational Study
Hao T. Nguyen, Nhi T. U. Pham, Tu N. A. Tran, Nhuong T. T. Nguyen, Thao T. P. Vu
COVE-1: A Phase 2, Open-Label Study to Evaluate Efficacy and Safety and the Optimal Regimen of VP-102, a Proprietary Drug–Device Product Containing Topical Cantharidin (0.7% w/v) Under Occlusion for the Treatment of Common Warts
Scott Guenthner, Wendy McFalda, Pearl Kwong, Kimberly Eads, Morgan McCafferty, Jayson Rieger, David K. Glover, Cynthia Willson, Patrick Burnett, Melissa Olivadoti
An Economic Analysis of the Impact of Homecare Drug Administration for Biologic Interventions Available for Plaque Psoriasis in the UK
William Green, Richard Stork, Aina Pi Blanque, Ayeda Nadeem
Dupilumab Demonstrates Rapid and Consistent Improvement in Extent and Signs of Atopic Dermatitis Across All Anatomical Regions in Pediatric Patients 6 Years of Age and Older
Eric L. Simpson, Amy S. Paller, Elaine C. Siegfried, Diamant Thaçi, Andreas Wollenberg, Michael J. Cork, Danielle Marcoux, Rui Huang, Zhen Chen, Ana B. Rossi, Brad Shumel, Debra Sierka, Ashish Bansal
Long-Term Proactive Treatment of Plaque Psoriasis with Calcipotriene/Betamethasone Dipropionate Foam Prolongs Remission and Reduces Relapses Irrespective of Patient Baseline Characteristics
Mark G. Lebwohl, Kim A. Papp, Marie Holst Mørch, Marie Y. Jablonski Bernasconi, Richard B. Warren
Efficacy and Safety Trends with Continuous, Long-Term Crisaborole Use in Patients Aged ≥ 2 Years with Mild-to-Moderate Atopic Dermatitis
Bob Geng, Adelaide A. Hebert, Liza Takiya, Lauren Miller, John L. Werth, Chuanbo Zang, Paul Sanders, Mark G. Lebwohl
Correction to: Efficacy and Safety Trends with Continuous, Long-Term Crisaborole Use in Patients Aged ≥ 2 Years with Mild-to-Moderate Atopic Dermatitis
Bob Geng, Adelaide A. Hebert, Liza Takiya, Lauren Miller, John L. Werth, Chuanbo Zang, Paul Sanders, Mark G. Lebwohl
Effect of Vitamin-Containing Amino Acid Supplements on Menopausal Symptoms and Age-Related Skin Changes: A Randomised, Double-Blind, Placebo-Controlled Study
Rie Yamashita, Masahiko Ooe, Yumiko Saya, Natsumi Sugisawa, Yumi Murakami, Hiroshi Matsunaka
Patient Journey in Atopic Dermatitis: The Real-World Scenario
Jose Manuel Carrascosa, Pablo de la Cueva, Raul de Lucas, Eduardo Fonseca, Ana Martín, Asunción Vicente, Maria Pilar Fortes, Susana Gómez, Francisco José Rebollo
The Use of Real-World Data to Evaluate the Association Between Atopic Dermatitis and Cardiovascular Disease: A Retrospective Claims Analysis
Jashin J. Wu, Caroline Amand, Daniel J. No, Puneet Mahajan, Abhijit Gadkari, Eric Ghorayeb, Mandeep Kaur, Andrew Korotzer, Laurent Eckert
Efficacy and Safety of Novel Formulation of Clobetasol Propionate 0.025% Cream in Indian Moderate-to-Severe Psoriasis Patients: Phase-2a, Randomized 3-Arm Study
Srinivas Sidgiddi, Syed Mujtaba Hussain Naqvi, Manjunath Shenoy, Devang Narayan Balraj, Jayesh Kothari, Sandesh Gupta, Rizwan Haq, Rajan Mittal, Suyog Mehta, Amey Mane
Real-World Satisfaction with Secukinumab in Clearing the Skin of Patients with Plaque Psoriasis through 24 Months of Follow-Up: Results from US Dermatology Electronic Medical Records
April W. Armstrong, Dhaval Patil, Eugenia Levi, Catherine B. McGuiness, Xin Wang, Yi Wang, Chi-Chang Chen, Elizabeth Nguyen, Paul S. Yamauchi
A Randomized Double-Blind Parallel-Group Study to Evaluate the Long-Term Effects of a Medical Device Containing 0.3% Octatrienoic Acid in the Treatment of Grade III Actinic Keratosis
Graziella Babino, Stefano Caccavale, Daniela Pinto, Anna Trink, Giammaria Giuliani, Fabio Rinaldi, Giuseppe Argenziano
Selectivity Profile of the Tyrosine Kinase 2 Inhibitor Deucravacitinib Compared with Janus Kinase 1/2/3 Inhibitors
Anjaneya Chimalakonda, James Burke, Lihong Cheng, Ian Catlett, Michael Tagen, Qihong Zhao, Aditya Patel, Jun Shen, Ihab G. Girgis, Subhashis Banerjee, John Throup
Health-Related Quality of Life of Patients with Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma Treated with Pembrolizumab in KEYNOTE-629
Brett G. M. Hughes, Rene Gonzalez Mendoza, Nicole Basset-Seguin, Olga Vornicova, Jacob Schachter, Abhishek Joshi, Nicolas Meyer, Florent Grange, Josep M. Piulats, Jessica R. Bauman, Diana Chirovsky, Pingye Zhang, Burak Gumuscu, Ramona F. Swaby, Jean-Jacques Grob
Beyond-Mild Psoriasis: A Consensus Statement on Calcipotriol and Betamethasone Dipropionate Foam for the Topical Treatment of Adult Patients
Roland Aschoff, Anthony Bewley, Annunziata Dattola, Clara De Simone, Mourad Lahfa, Mar Llamas-Velasco, Antonio Martorell, Mira Pavlovic, Michael Sticherling
Practical Management of Patients with Atopic Dermatitis on Dupilumab
Kim A. Papp, Chih-ho Hong, M. Perla Lansang, Irina Turchin, David N. Adam, Jennifer R. Beecker, Robert Bissonnette, Melinda J. Gooderham, Carolyn Jack, Marissa Joseph, Charles W. Lynde, Neil H. Shear
Recognition and Management of Hereditary Angioedema: Best Practices for Dermatologists
Michael E. Manning
Key Clinical Adverse Events in Patients with Advanced Basal Cell Carcinoma Treated with Sonidegib or Vismodegib: A Post Hoc Analysis
Ralf Gutzmer, Carmen Loquai, Caroline Robert, Brigitte Dréno, Alexander Guminski, Karl Lewis, Ramon Arntz, Serena Martelli, Nicholas Squittieri, Meenal Kheterpal
A Survey of Community Dermatologists Reveals the Unnecessary Impact of Trial-and-Error Behavior on the Psoriasis Biologic Treatment Paradigm
Bruce Strober, David Pariser, Ann Deren-Lewis, Tobin J. Dickerson, Mark Lebwohl, Alan Menter
Itraconazole Oral Solution for a Case of Infantile Hemangioma: Monitoring the Efficacy by Dermoscopy and MRI
Ying Huang, Xin Ran, Xiaoxi Xu, Sushmita Pradhan, Jiayu Sun, Hehan Tang, Yuping Ran